Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autosomal Dominant Hypocalcemia Type 1 (ADH1)”

5 trials

Showing 5 of 5 results

Testing effectiveness (Phase 2)Study completedNCT00743782
What this trial is testing

Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism

Who this might be right for
HypoparathyroidismHypocalcemiaAutoimmune Polyendocrine Syndrome Type 1+1 more
National Institutes of Health Clinical Center (CC) 21
Large-scale testing (Phase 3)Active Not RecruitingNCT05680818
What this trial is testing

Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1

Who this might be right for
Autosomal Dominant Hypocalcemia (ADH)
Calcilytix Therapeutics, Inc., a BridgeBio company 67
Not applicableActive Not RecruitingNCT05227287
What this trial is testing

ADH1 and ADH2 Disease Monitoring Study (DMS)

Who this might be right for
Autosomal Dominant Hypocalcemia
Calcilytix Therapeutics, Inc., a BridgeBio company 95
Testing effectiveness (Phase 2)Study completedNCT04581629
What this trial is testing

Safety, Tolerability, and Efficacy of Encaleret in Participants With Autosomal Dominant Hypocalcemia (ADH) Type 1

Who this might be right for
Autosomal Dominant Hypocalcemia (ADH)Autosomal Dominant Hypocalcemia Type 1 (ADH1)
Calcilytix Therapeutics, Inc., a BridgeBio company 13
Large-scale testing (Phase 3)Looking for participantsNCT07080385
What this trial is testing

Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)

Who this might be right for
Autosomal Dominant Hypocalcemia Type 1 (ADH1)
Calcilytix Therapeutics, Inc., a BridgeBio company 28

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation